Panache Digilife Limited – Compliance Update (29 Apr 2026)

Key Highlights

• Fundraising instrument: Preferential issue of convertible warrants
• Date of allotment: 5 January 2026
• Amount raised: ₹4,77,49,500 (75% of total consideration received)
• Purpose of funds: Business growth, general corporate purposes, working‑capital requirements
• Utilization status: 100% of the amount utilized as originally intended
• Deviation: None reported
• Audit Committee: Reviewed and provided no comments
• Regulatory compliance: Statement filed under SEBI Regulation 32 and related circulars

Financial Implications

• The full deployment of the raised capital into growth and working‑capital activities should support operational scaling without diluting shareholder value.
• No additional debt or equity dilution beyond the convertible warrants already accounted for.

Strategic Perspective

• Reinforces management’s commitment to transparent capital deployment.
• Funds are earmarked for expanding the company’s core business, which aligns with its long‑term growth roadmap.

Regulatory & Governance

• The filing satisfies SEBI’s Listing Obligations and Disclosure Requirements, demonstrating adherence to corporate governance standards.
• Audit Committee oversight adds an extra layer of assurance for stakeholders.

Investor Take‑aways

• Risk: Minimal – no deviation means no unexpected financial exposure.
• Opportunity: Continued confidence in the company’s ability to execute its growth plan using the capital raised.
• Action: Investors can view this compliance update as a green flag for governance and capital discipline.

Prepared on 29 April 2026 for Panache Digilife Limited shareholders and potential investors.